IW-9179
ICP-112-201
Phase 2 small_molecule terminated
Quick answer
IW-9179 for Dyspepsia is a Phase 2 program (small_molecule) at IRONWOOD PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- IRONWOOD PHARMACEUTICALS INC
- Indication
- Dyspepsia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated